Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 5 November 2026.
Announcements
6,266
Total raised
£165B
disclosed amounts
This month
£202M
raised so far
The funding round was led by Lingotto, imec.xpand, and Northern Gritstone.
"Fully Homomorphic Encryption has the power to unlock the full value of data – but despite its advantages, it is currently unviable for anything beyond basic processes – this is where Optalysys comes in. Our Enable technology allows us to turbo boost the workflows and address the underlying bottlenecks that hold FHE back."
The Oxford-based medical technology company secured backing from Lauxera Capital Partners to expand its US footprint and advance research pipelines.
"Lauxera is proud and honoured to back the OrganOx team and its global commercial scale-up. This is the ninth investment made by Lauxera Growth I, a growth buy-out fund dedicated to investing in commercial-stage European and North American HealthTech businesses."
The Series A round included backing from British Patient Capital, F-Prime Capital, and Sofinnova Partners.
"Tenpoint Therapeutics has been built on the pioneering work of its scientific founders who are recognised leaders in ocular therapies. Their vision combined with research excellence provides the best foundation to develop treatments that could be gamechangers for millions of patients worldwide. Through Future Fund: Breakthrough, we are delighted to support this truly innovative British business with the funding to take the business to the next level."
The London scaleup will use the capital to scale its presence in the United States and broaden its artificial intelligence offerings.
"AI represents one of the biggest leaps forward in technology in recent years and our unique approach to data sourcing from humans positions us to make these systems more accountable and less biased. The funding we have secured will fuel our growth in the AI space, especially in the US, bolstering our commitment to human-guided AI development during this pivotal moment in the technology’s progression."
The pre-seed round was led by Science Creates Ventures with backing from a syndicate of institutional and angel investors.
"The UK would massively benefit from delivering major infrastructure projects on time and on budget, and through increased productivity by reducing the time it takes to bring such projects to the point of benefitting people. A big part of this is the difficulty found in mapping the complex unseen environments and hidden critical infrastructure that resides under the ground. Considerable budgets are allocated to ensure that unexpected obstacles can be overcome. On HS2 alone, the contingency for unforeseen ground conditions is £248m."
